What's breaking now, across thousands of outlets.
Vanguard's ultra-low 0.06% expense ratio appeals to cost-conscious investors, while Invesco's small-cap strategy delivered 22.3% returns over the past year.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Kincellis Advanced Therapies is a US-based contract development and manufacturing organization for cell and advanced-therapy modalities, operating roughly 140,000 square feet of GMP manufacturing…
Broadcom and Oracle have underperformed over the past year, but they could jump significantly given their impressive growth and bright prospects.
Rockhopper Exploration has completed a plan to raise fresh funds from shareholders, expecting to bring in around US$200 million to fund its investment in the Sea Lion prospect in the Falklands.
Rabobank's Senior Macro Strategist Bas van Geffen discusses the latest FOMC decision, noting a unanimous 25 bps hike in the Federal funds rate and a shift to a higher policy rate trajectory for…
The yoga and athleisure apparel maker faces existential challenges.
Nick Kunze of Sanlam Private Wealth discusses the US Fed’s decision to hike interest rates, Brent crude staying above $100 a barrel, oil supply risks and the market response.
